This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovations of Joerg Thomas: A Groundbreaking Inventor in Biopharmaceuticals
Introduction: Joerg Thomas is an accomplished inventor based in Munich, Germany, known for his innovative contributions to the field of biopharmaceuticals. With a keen focus on developing therapeutic antibodies, he has made significant strides in addressing critical medical challenges.
Latest Patents: Joerg Thomas holds one patent titled "Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies." This groundbreaking invention pertains to bispecific, bivalent antibodies that target human vascular endothelial growth factor (VEGF/VEGF-A) as well as human angiopoietin-2 (ANG-2). The patent outlines methods for producing these antibodies, pharmaceutical compositions containing them, and their various applications in medical treatments.
Career Highlights: Joerg Thomas is a pivotal member of Hoffmann-La Roche Inc., a leading pharmaceutical company dedicated to research and development in healthcare. His work focuses on creating innovative therapeutic solutions that can improve patient outcomes.
Collaborations: Throughout his career, Joerg Thomas has collaborated with talented coworkers such as Monika Baehner and Sabine Imhof-Jung. These partnerships emphasize the importance of teamwork in driving innovation in the biotech sector.
Conclusion: Joerg Thomas exemplifies the spirit of innovation within the biopharmaceutical industry. His patent on bispecific antibodies represents a significant advancement in targeted therapies, showcasing his commitment to improving healthcare through scientific discovery and collaboration.